PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Combination therapy may help decrease sleep apnea symptoms at higher altitudes

2012-12-12
(Press-News.org) CHICAGO – For individuals with obstructive sleep apnea traveling to higher altitudes (which may exacerbate symptoms), use of a combination therapy resulted in improvement in symptoms including reduced insomnia and better control of sleep apnea, according to a preliminary study published in the December 12 issue of JAMA.

As travel to the mountains for professional and recreational activities is increasingly popular, involving millions of persons worldwide, the estimated number of patients with obstructive sleep apnea (OSA) among mountain tourists is also high, and may involve several hundred thousand persons each year, which may expose them to hypoxemia (abnormally low levels of oxygen in the blood) and exacerbation of sleep apnea. "The treatment in this setting is not established," according to background information in the article.

Tsogyal D. Latshang, M.D., of the University of Zurich, Switzerland, and colleagues conducted a study to evaluate whether taking of the drug acetazolamide (a respiratory stimulant used to treat acute mountain sickness and high-altitude periodic breathing) combined with auto-adjusted continuous positive airway pressure (autoCPAP, computer-controlled continuous mask pressure adjustment) would provide better oxygenation and control of sleep-related breathing disturbances than autoCPAP alone in patients with OSA spending a few days at moderate altitude. The randomized trial included 51 patients with OSA living below an altitude of 800 meters (2,625 feet) and receiving CPAP therapy who underwent studies at a university hospital at 490 meters (1,608 feet) and resorts in Swiss mountain villages at 1,630 meters (5,348 feet) and 2,590 meters (8,497 feet) in the summer of 2009. Patients were studied during 2 stays of 3 days each in the mountain villages. At altitude, patients either took acetazolamide (750 mg/d) or placebo in addition to autoCPAP.

The researchers found that at 1,630 meters and 2,590 meters, combined acetazolamide and autoCPAP treatment was associated with higher oxygen saturation and a lower apnea/hypopnea index (AHI) compared with placebo and autoCPAP. AutoCPAP and acetazolamide increased the median [midpoint] nocturnal oxygen saturation by 1.0 percent at 1,630 meters and by 2.0 percent at 2,590 meters. Also, acetazolamide and autoCPAP resulted in better control of sleep apnea at these altitudes than placebo and autoCPAP: median apnea/ hypopnea index was 5.8 events per hour (5.8/h) and 6.8/h vs. 10.7/h and 19.3/h, respectively; median reduction was 3.2/h and 9.2/h. Median night-time spent with oxygen saturation less than 90 percent at 2,590 meters was 13 percent vs. 57 percent.

"The current randomized, placebo-controlled, double-blind trial provides several novel findings that are clinically relevant for patients with OSA traveling to altitude. First, the data show that combined therapy with acetazolamide and autoCPAP provides a better oxygenation during sleep and wakefulness, prevents an exacerbation of sleep apnea at altitude, and reduces the time spent awake during nights compared with autoCPAP alone. Second, the results demonstrate that autoCPAP alone is an effective therapy for obstructive apneas/hypopneas even at altitude where central apneas/hypopneas emerge," the authors write.

"Our study provides important information for patients with OSA planning a stay at altitude because they can continue using their CPAP in autoadjusting mode during altitude travel and enhance this treatment with acetazolamide if they want to spend less time awake at night, to achieve a higher arterial oxygen saturation and an optimal control of sleep apnea." ### (JAMA. 2012;308(22):2390-2398)

Editor's Note: Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

To contact corresponding author Konrad E. Bloch, M.D., email konrad.bloch@usz.ch.


ELSE PRESS RELEASES FROM THIS DATE:

Long-term public health support needed to tackle infectious disease outbreaks

2012-12-12
Outbreaks of infectious diseases, such as swine flu (H1N1) threaten global health and should be considered by funding agencies and humanitarian organizations as development issues rather than emergency situations, requiring long-term support and investment, according to US experts writing in this week's PLOS Medicine. The authors from several US institutions, led by Tiffany Bogich from Princeton University, reached these conclusions by reviewing nearly 400 serious international public health events. They found that the disruption to, or lack of, public health infrastructure ...

Industry sponsorship leads to bias in reported findings of clinical trials

2012-12-12
Studies reporting the results of industry sponsored clinical trials present a more favourable picture of the effects of drugs and medical devices than those reporting on non-industry sponsored trials, according to a new Cochrane systematic review. The researchers call for a rethink of the way that industry bias is handled in medical guidelines and reviews. The outcomes of clinical trials influence the recommendations that doctors make about drugs and other medical interventions. Therefore, it is important that trials are designed, carried out and reported on without bias ...

Just a spoonful: Sweet taste comforts babies during injections

2012-12-12
The sweet taste of sugar may provide some comfort for babies during immunisations, according to a new Cochrane systematic review. Researchers found babies did not cry for as long if they were given drops of sugar solution before injections. Between birth and 18 months, babies may have as many as 15 injections. It is not certain whether babies feel pain in the same way as older children and adults, or whether they are simply unable to express it. Recent evidence has proven they do feel pain and efforts have been made to reduce pain caused by injections through the use ...

Psychological therapies improve life for children with post-traumatic stress disorder

2012-12-12
Children suffering post-traumatic stress disorder (PTSD) as a result of traumatic events, including child abuse, may benefit from psychological therapies, according to a review published in The Cochrane Library. In the first systematic review of PTSD in young people, researchers found that children and teenagers diagnosed with PTSD showed signs of improvement up to three months following treatment and called for more studies to assess long-term benefits. People who develop PTSD have usually experienced extreme traumatic events, such as abuse, war or natural disasters. ...

Resurrection of extinct enzymes reveals evolutionary strategy for the invention of new functions

2012-12-12
How does evolution innovate? We exist because our ancestors have had the ability to adapt successfully to changes in their environment; however, merely examining present-day organisms can limit our understanding of the actual evolutionary processes because the crucial events have been masked by the passage of aeons – what we need is a time machine. Scientists from VIB, KU Leuven, University of Ghent and Harvard have done the next-best thing; by reconstructing DNA and proteins from prehistoric yeast cells, they were able to directly examine the evolutionary forces that have ...

Even moderate smoking associated with sudden death risk in women

2012-12-12
Women who are even light-to-moderate cigarette smokers may be significantly more likely than nonsmokers to suffer sudden cardiac death, according to new research in Circulation: Arrhythmia & Electrophysiology, an American Heart Association journal. The findings indicate long-term smokers may be at even greater risk. But quitting smoking can reduce and eliminate the risk over time. "Cigarette smoking is a known risk factor for sudden cardiac death, but until now, we didn't know how the quantity and duration of smoking effected the risk among apparently healthy women, nor ...

Concussions affect children's brains even after symptoms subside

2012-12-12
Washington, DC — Brain changes in children who have sustained a mild traumatic brain injury, or concussion, persist for months following injury — even after the symptoms of the injury are gone, according to a study published in the December 12 issue of The Journal of Neuroscience. The findings highlight the potential benefit of using advanced imaging techniques to monitor recovery in children following concussions. Despite growing concerns over the risk of concussions in youth, the majority of research examining their effects on the brain has involved adults. These ...

Manipulative therapies may be a beneficial treatment for infantile colic

2012-12-12
A Cochrane review of studies into manipulative therapies for colic, by the University of Southampton, suggests that the treatment technique may be of some benefit. Infantile colic is a distressing problem, characterised by excessive crying of infants and it is the most common complaint seen by physicians in the first 16 weeks of a child's life. It is usually considered a benign disorder because the symptoms generally disappear by the age of five or six months. However, the degree of distress caused to parents and family life is such that physicians often feel the ...

Discovery of tiny fossil new to science

Discovery of tiny fossil new to science
2012-12-12
'It is exciting to discover that a common group of fossils that we thought we knew a lot about may well have been hood-winking us as to their true identity, which we now realise because we have their beautifully fossilised soft-parts. A case of a 'wolf in sheep's clothing''- Professor David Siveter, University of Leicester An international team of researchers have made an extremely rare discovery of a species of animal - related to crabs, lobsters and shrimps – that is new to science. Scientists from the universities of Leicester, Oxford, Imperial and Yale have announced ...

Was the sauropod dinosaurs' large size due to plant food? Scientists argue old idea still has legs

2012-12-12
The long necked sauropod dinosaurs were the largest land animals ever to walk the Earth – but why were they so large? A decade ago a team of plant ecologists from South Africa suggested that this was due to the nature of the plant food they ate, however these ideas have fallen out of favour with many dinosaur researchers. Now Liverpool John Moores University's (LJMU's) Dr David Wilkinson and Professor Graeme Ruxton of University of St Andrews, Scotland, argue that this idea still has legs. The results have been published in the journal Functional Ecology published by ...

LAST 30 PRESS RELEASES:

Cell therapy improves overall survival of patients with colorectal cancer

Food packaging is a source of micro- and nanoplastics in food

New study sheds light on the effectiveness of measures to solve the 'migration crisis'

Strategy to prevent age-related macular degeneration identified

500 bird species face extinction within the next century

Genetic markers for depression reveal consistent patterns in psychiatric treatment outcomes

Deep-sea mining could harm remote ocean ecosystems

Stanford researcher develops machine learning models to decode brain aging at cellular level

AI shortens the development time of new materials

Insulin on edge: Study identifies stress-triggered gene behind diabetes

Wildlife forensic scientists develop new tool to detect elephant ivory disguised as legal mammoth ivory

Organ preservation strategies: Extended sleeve lobectomy after neoadjuvant immunochemotherapy offers optimal option for centrally located NSCLC

Doubts cast over suggestions incestuous ‘god-kings’ ruled during Neolithic Ireland

Interpretation on feature groups for tree models

Military discharge is a time of challenge and opportunity

Common pregnancy complications may be a signal of future stroke risk

Barcodes uncover early blueprints of our cellular origins

Stanford Medicine-led phase 3 trial shows gene therapy skin grafts help epidermolysis bullosa

‘Pill-on-a-thread’ could replace endoscopies for half of all patients being monitored for esophageal cancer risk

Study casts doubt on ‘incestuous royalty’ in Neolithic Ireland

Heart valve developed at UC Irvine shines in early-stage preclinical testing

In diseases due to exposure to toxic particles like gout, macrophages elicit separate pathways for inflammation and lysosomal function

Zoning out could be beneficial—and may actually help us learn faster

Weekly semaglutide improves blood sugar and weight in adults with Type 1 diabetes

Concerned father, statistician develops software to improve skills therapy

Your smartwatch might know you’re sick before you do — and it might help stop pandemics

ImmunoPET tracer enhances early detection of liver cancer

AI-based brain-mapping software receives FDA market authorization

New PET tracer identifies diverse invasive mold infections behind life-threatening illnesses in cancer and transplant patients

Current Pharmaceutical Analysis (CPA) achieves notable impact factor growth in latest journal citation reports

[Press-News.org] Combination therapy may help decrease sleep apnea symptoms at higher altitudes